Independence of HIF1a and androgen signaling pathways in prostate cancer
<br><strong>Background: </strong>Therapeutic targeting of the androgen signaling pathway is a mainstay treatment for prostate cancer. Although initially effective, resistance to androgen targeted therapies develops followed by disease progression to castrate-resistant prostate canc...
Asıl Yazarlar: | , , , , , , , , , , , , , , , , |
---|---|
Materyal Türü: | Journal article |
Dil: | English |
Baskı/Yayın Bilgisi: |
Springer Nature
2020
|